Baran and Balci
of the solvent gave tetraacetate 12. Crystallization from hexane/
EtOAc 4:1 gave tetraacetate (12) (1,38 g, 77%). Pure white crystals,
mp 128-131 °C. H NMR (400 MHz, CDCl3) δ 5.39-5.35 (m,
3041, 2961, 2866, 1739, 1440, 1376, 1244, 1049. Anal. Calcd for
C12H16O5: C, 59.99; H, 6.71. Found: C, 59.87; H, 6.92.
1
cis-Hydroxylation of 5. 3aS(R),4S(R),5S(R),6R(S),7R(S),7aR(S),-
4,6,7-Tris(acetyloxy)octahydro-2-benzofuran-5-yl Acetate (8) and
3aS(R),4S(R),5S(R),6S(S),7S(S),7aR(S),-4,6,7-Tris(acetyloxy)octahy-
dro-2-benzofuran-5-yl Acetate (16). An 8.5 g (35.4 mmol) portion
of diacetate 15 was submitted to cis-hydroxylation reaction as
described above. Acetylation of the residue gave a crude mixture
consisting of 8 and 16 (10.63 g), which was separated by silica gel
chromatography eluting with EtOAc/hexane (1:1). The first fraction
was the symmetrical diacetate 8 (5.7 g, 45%). The second fraction
was identified as 16 (4.6 g, 36%). Colorless crystals from EtOAc/
2H), 5.16-5.11 (m, 2H), 4.01 (t, A-part of AB-system, J ) 9.1
Hz, 1H), 3.80 (d, A-part of AB-system, J ) 9.0 Hz, 1H), 3.72,
(dd, B-part of AB-system, J ) 9.1 and 5.2 Hz, 1H), 3.70 (t, B-part
of AB-system, J ) 9.0 Hz, 1H), 2.74-2.66 (m, 1H), 2.61-2.55
(m, 1H), 2.12 (s, 3H), 2.05 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H); 13
C
NMR (100 MHz, CDCl3) δ 170.0 (2C), 169.9, 169.7, 71.2, 71.0,
70.97, 69.6, 68.0, 67.9, 42.1, 41.8, 20,9, 20.7, 20.6, 20.55.
1H NMR (400 MHz, benzene-d6) δ 5.76 (dd, J ) 9.8 and 9.3
Hz, 1H), 5.54 (t, J ) 3.2 Hz, 1H), 5.44 (t, J ) 9.8 Hz, 1H), 5.37
(dd, J ) 9.3, J ) 3.2 Hz), 3.88 (d, A-part of AB-system, J ) 8.8
Hz, 1H) 3.57 (t, A-part of AB-system, J ) 9.1 Hz, 1H), 3.45 (m,
B-parts of AB-systems) 2H), 2.40-2.34 (m, 1H), 2.30-2.22 (m,
1H), 1.83 (s, 3H), 1.81 (s, 3H), 1.78 (s, 3H); 13C NMR (100 MHz,
benzene-d6) δ 169.4, 169.3, 169.1 (2C), 71.5, 71.2, 70.7, 70.0, 68.1,
67.6, 42.14, 42.06. 20.11, 20.07, 20.00 (2C); IR (KBr, cm-1) 3014,
2943, 1753, 1442, 1375, 1232, 1043, 906. Anal. Calcd for C16H22O9:
C, 53.63; H, 6.19. Found: C, 53.58; H, 5.97.
1R(S),2R(S)3S(R),4S(R),5R(S),6S(R)-2,3,4-(Acetyloxy)-5,6-
bis[(acetyloxy)methyl]cyclohexyl Acetate (13). To a stirred solu-
tion of 2.0 g (7.81 mmol) of epoxydiacetate (11b) in AcOH/AcOH
(15 mL 1:1) was added 0.15 g (1.55 mmol) sulfamic acid at room
temperature, and then the mixture was refluxed for 24 h. The
reaction mixture was worked up as described above to give 13 as
colorless liquid, (3.19 g, 89%). 1H NMR (400 MHz, CDCl3) δ 5.41
(t, J ) 2.7 Hz, 1H), 5.32 (t, J ) 10.6 Hz, 1H), 5.24 (dd, J ) 10.6
and 10.1 Hz, 1H), 5.13 (dd, J ) 10.1 and 3.0 Hz, 1H), 4.27-4.17
(m, 3H), 3.93 (dd, J ) 11.7 and 3.8 Hz, 1H), 2.58-2.51 (m, 1H),
2.40-2.36 (m, 1H), 2.08 (s, 6H), 1.96 (s, 6H), 1.94 (s, 3H), 1.92
(s, 3H); 13C NMR (100-MHz, CDCl3) δ 170.36, 170.23, 170.03,
169.88, 169.79 169.6, 71.6, 70.1, 69.8, 69.6, 61.5, 61.1, 39.3, 36.8,
20.9, 20.8, 20.6, 20.58, 20.5 (2C); IR (KBr, cm-1) 2964, 1746,
1433, 1369, 1230, 1040, 952. Anal. Calcd for C20H28O12: C, 52.17;
H, 6.13; Found: C, 51.84; H, 6.09.
1
hexane (1:2), mp 94-96 °C. H NMR (400 MHz, CDCl3) δ 5.46
(dd, J ) 5.2 and 3.7 Hz, 1H), 5.34 (dd, J ) 6.8 and 2.8 Hz, 1H),
5.26 (m, 2H), 3.90 (dd, J ) 8.6 and 6.3 Hz, 1H) 3.83-3.80 (m,
2H), 3.46 (dd, J ) 8.3 and 5.6 Hz, 1H), 2.82-2.75 (m, 1H),
2.58-2.52 (m, 1H), 2.01 (s, 9H), 1.99 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 170.1, 170.0, 169.6 (2C), 69.9, 69.3, 68.9, 68.4, 68.1,
67.6, 41.0, 39.5, 20.81 (2C), 20.7, 20.7; IR (KBr, cm-1) 2968, 2876,
1752, 1437, 1371, 1340, 1211, 1100, 1061. Anal. Calcd for
C16H22O9: C, 53.63; H, 6.19. Found: C, 53.68; H, 6.51.
1R(S),2R(S)3R(S),4R(S),5R(S),6S(R)-2,3,4-(Acetyloxy)-5,6-
bis[(acetyloxy)methyl]-cyclohexyl Acetate (19). The tetraacetate
16 (2.0 g, 5.58 mmol) was reacted with sulfamic acid as described
1
above to give 17: 2.14 g (83%), colorless liquid; H NMR (400
MHz, CDCl3) δ 5.57 (bd, 2H); 5.31 (dd, A-part of AB-system, J
) 10.7 and 2.8 Hz, 1H), 5.25 (dd, B-part of AB-system, J ) 10.7
and 3.0 Hz, 1H), 4.36 (dd, J ) 11.8 and 5.1 Hz, 1H), 4.19 (t, J )
10.7 Hz, 1H), 4.16-4.01 (m, 2H), 2.63-2.61 (m, 1H), 2.38-2.34
(m, 1H), 2.13 (s, 3H), 2.12 (s, 3H), 2.09 (s, 3H), 2.06 (s, 3H),
2.01(s, 3H), 1.99 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.6,
170.5, 170.0, 169.9, 169.7, 169.6, 69.1, 68.4, 66.7, 61.6, 60.9, 60.3,
39.9, 35.4, 20.9, 20.8, 20.7 (2C), 20.65, 20.60; IR (KBr, cm-1
)
2970, 1736, 1373, 1234, 1174, 1094, 1036. Anal. Calcd for
C20H28O12: C, 52.17; H, 6.13. Found: C, 52.02; H, 6.05.
(1R(S),2R(S),3R(S),3R(S),5R(S),6S(R)-Bis(hydroxymethyl)cy-
clohexane-1,2,3,4-tetrol (18). One gram (2.17 mmol) pof hexaac-
etate 17 was hydrolyzed with ammonia as described above to give
the free hexol 18. The residue was crystallized from EtOH to give
0.4 g (88%) of 18 as a colorless powder, mp 156-158 °C. 1H NMR
(400 MHz, D2O) δ 4.7 (bs, 6H, -OH), 4.04 (bs, 1H), 3.92 (bs, 1H),
3.74 (dd, J ) 10.0 Hz, 1H), 3.67-3.42 (m, 5H), 2.07 (m, 1H),
2.03 (m, 1H); 13C NMR (100 MHz, D2O) δ 71.0 (2C), 69.3, 68.8,
60.1, 59.4, 44.1, 38.6; IR (KBr, cm-1) 3458, 2940, 2868, 1482,
1433, 1372, 1238, 1186, 1044. Anal. Calcd for C8H16O6: C, 46.15;
H, 7.75. Found: C, 46.53; H, 7.94.
Reaction of Diacetate 15 with m-Chloroperbenzoic Acid.
Diacetate 15 (1.5 g, 6.25 mmol) was dissolved in 200 mL of
chloroform, m-CPBA (3.0 g, 12 mmol, 70%) was added, and then
the reaction was stirred at reflux temperature for 3 weeks (every
2-3 days, small portions (200 mg) of m-CPBA were added). The
reaction mixture was worked up as described in the general
procedure. Evaporation of solvent under reduced pressure gave a
oily residue (1.5 g), which was treated with 0.5 mL of pyridine
and 1 mL of acetic anhydride. The resulting solution was stirred at
room temperature for 5 h. The mixture consisting of 19, 20, 21,
and 22 was chromatographed on a silica gel column (50 g) eluting
with hexane/EtOAc 3:1. Four compounds were isolates in the
following order: 21 (92 mg, 4.4%), 22 (50 mg, 2.4%), 19 (816
mg, 51%), 20 (416, 26%).
1R(S),2R(S)3S(R),4S(R),5R(S),6S(R)-Bis(hydroxymethyl)cy-
clohexane-1,2,3,4-tetrol (14). One gram (2.17 mmol) of hexaacetate
13 was dissolved in methanol (75 mL), NH3(g) was passed through
the solution for 5 h, and the solvent concentrated in vacuo to give
429 mg (2.04 mmol, 94%) white solid from EtOH, mp 175-
1
177 °C. H NMR (400 MHz, DMSO) δ 4.55 (bs, 1H), 4.43 (bs,
2H), 4.34 (bs, 1H), 4.27 (bs, 2H), 3.88 (bs, 1H), 3.703.67 (m, 1H),
3.53-3.50 (m, 1H), 3.46-3.43 (m, 1H), 3.37 (bs, 1H), 3.3 (bd, J
) 7.9 Hz, 1H), 3.27-3.17 (m, 2H), 2.01-1.94 (m, 2H). 13C NMR
(100 MHz, DMSO) 75.4, 71.9, 71.4, 70.2, 60.9, 58.6, 43.3, 40.1;
IR (KBr, cm-1) 3400, 2931, 2904, 1447, 1382, 1343, 1324, 1256,
1239, 1214, 1196. Anal. Calcd for C8H16O6: C, 46.15; H, 7.75.
Found: C, 46.52; H, 7.49.
3aS(R),4S(R),5S(R),7aR(S)-4-(Acetyloxy)-1,3,3a,4,5,7a-hexahy-
dro-2-benzofuran-5-yl Acetate (15). The diene 5 (8.0 g, 65.6
mmol), NMO (8.91 g, 77.5 mmol), and OsO4 (ca. 20 mg) in 30
mL of H2O and acetone (1:1) were reacted as described above.
The residue was dissolved in pyridine (10 mL) and Ac2O (15 mL)
and stirred for 25 h at room temperature. The product was
hydrolyzed with aqueous ice-cooled HCl (100 mL, 20%), neutral-
ized with aqueous NaHCO3, dried (Na2SO4), filtered, and evaporated
to give colorless liquid (12.43 g). After filtration of over silica gel
(150 g) with EtOAc, evaporation of solvent and crystallization from
EtOAc/hexane (1:2) gave 11.02 g (70%) of colorless crystals, mp
1
98-100 °C. H NMR (400 MHz, CDCl3) δ 5.96 (dd, A-part of
Data for 4,6-Bis(acetyloxy)-7-chlorooctahydro-2-benzofuran-
5-yl Acetate (21). 1H NMR (400 MHz, CDCl3) δ 5.56 (t, J ) 2.6
Hz, 1H), 5.24 (dd, J ) 11.0 and 2.6 Hz, 1H), 4.96 (dd, J ) 11.0
and 2.2 Hz, 1H), 4.51 (dd, J ) 11.2 and 6.4 Hz, 1H), 4.09 (t, J )
9.2 Hz, 1H), 3.80-3.88 (m, 3H), 3.25-3.12 (m, 1H), 2.60-2.53
(m, 1H), 2.14 (s, 3H), 2.06 (s, 3H), 2.01(s, 3H); 13C NMR (100
MHz, CDCl3) δ 170.1, 170.0, 169.7, 71.6, 70.6, 70.2, 68.7, 68.3,
55.6, 43.8, 41.0, 21.0, 20.9, 20.8; IR (KBr, cm-1) 2957, 2877, 1738,
AB-system, J ) 9.8 and 3.8 Hz, 1H), 5.83 (ddd, B-part of AB-
system, J ) 9.8, 5.4 and 1.6 Hz, 1H), 5.46 (dd, J ) 3.8 and 3.3
Hz), 5.01 (dd, J ) 10.7 and 3.3 Hz, 1H), 4.03 (t, J ) 8.5 Hz, 1H),
3.91 (dd, A-part of AB-system, J ) 9.3 and 6.5 Hz, 1H), 3.74 (dd,
B-part of AB-system, J ) 9.3 and 2.8 Hz, 1H), 3.48 (t, J ) 8.5
Hz, 1H), 3.09-3.04 (m, 1H), 2.79-2.72 (m, 1H), 2.07 (s, 3H),
2.04 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.4, 170.3, 132.1,
123.7, 71.8, 70.6, 70.1, 64.9, 40.4, 37.8, 20.9, 20.8; IR (KBr, cm-1
)
94 J. Org. Chem. Vol. 74, No. 1, 2009